Skip to content

Oklahoma Medicaid

Does Oklahoma Medicaid cover Zepbound?

Yes. Oklahoma Medicaid covers Zepbound for obstructive sleep apnea (OSA) with prior authorization if your BMI is 30 or higher. Other policy requirements and your plan's benefits also apply.

Policy document

  • Medicaid: Covered with requirements. See the qualification pathways below.

Earliest policy review June 4, 2026. How we verify · Check your exact plan

Full requirements: Zepbound for Obstructive Sleep Apnea (OSA) (1 plan type)

Applies to Medicaid plans.

Covered with requirements

Qualification pathways

You can qualify through any one of these.

OSA — initial approval

All of:

  • FDA approved indication of moderate to severe OSA in members with obesity
  • Member is 18 years of age or older
  • Moderate to severe OSA defined as AHI ≥ 15 determined by PSG or technically adequate HSAT (AHI value must be provided)
  • BMI ≥ 30 kg/m2
  • No central or mixed sleep apnea
  • No T1DM or T2DM
  • HbA1c < 6.5%
  • Not using Zepbound in combination with other tirzepatide-containing products or any GLP-1 receptor agonist
  • Diet and exercise used in conjunction (clinical documentation required)

Documentation to bring

  • AHI value from polysomnography (PSG) or home sleep apnea testing (HSAT) with a technically adequate device confirming AHI ≥ 15
  • Baseline BMI ≥ 30 kg/m2
  • HbA1c lab result confirming < 6.5%
  • Clinical documentation (e.g., office notes) of diet and exercise program
  • Confirmation member does not have central or mixed sleep apnea
  • Confirmation member does not have T1DM or T2DM
  • Confirmation member will not use Zepbound in combination with other tirzepatide-containing products or any GLP-1 receptor agonist
  • For Zepbound vials: patient-specific, clinically significant reason why member cannot use the pen or KwikPen formulation

Quantity limits

  • all pen and vial strengths — 4 pens or vials (2mL) per 28 days
  • KwikPen — 1 KwikPen (2.4mL) per 28 days

Approval and renewal

  • Initial approval: 2 months
  • Renewal: every 12 months
  • Renewal: Member is tolerating maintenance dosing and adherent to therapy; clinical improvement of OSA (e.g., patient-reported improvement in daytime sleepiness, partner-reported reduction of snoring episodes or pauses in breathing, reduction of AHI events); member has not developed T1DM or T2DM; member is continuing a reduced calorie diet and increased physical activity in conjunction with Zepbound.
  • Renewal: Staying on a maintenance dose of at least 5 mg.

Not covered when

  • Type 2 diabetes mellitus (T2DM excluded; HbA1c must be <6.5%)
  • Central or mixed sleep apnea
  • Concurrent use with other tirzepatide-containing products or any GLP-1 receptor agonist
  • Obese members without OSA will not be approved
  • Members who cannot tolerate dose escalation to at least 5mg after additional 8-week approval will not be approved for continuation
  • Zepbound should be discontinued if member cannot tolerate at least 5mg once weekly maintenance dosing
  • Zepbound vials are non-preferred over pens and KwikPens; vials require patient-specific justification
  • Type 1 diabetes

Policy note: Initial approvals are for 8-week titration periods per dose; a separate PA must be submitted for each dose. An additional 8 weeks per dose may be approved for intolerable adverse effects during escalation with documentation. Members who cannot tolerate escalation to at least 5mg after additional 8-week approval will not be approved for continuation. Subsequent (maintenance) approvals are for 1 year for maintenance doses of 5mg to 15mg. OSA must be moderate to severe (AHI ≥ 15). PAP/CPAP trial is NOT required by this policy. Last modified date on the Metabolic Disorders page is April 24, 2026.

verified June 4, 2026 · source: Policy 385 · View policy document (PDF)

Open on its own page →

Questions people ask
Does Oklahoma Medicaid cover Zepbound?
Yes. Oklahoma Medicaid covers Zepbound for obstructive sleep apnea (OSA) with prior authorization if your BMI is 30 or higher. Other policy requirements and your plan's benefits also apply.
How long does a Zepbound approval last with Oklahoma Medicaid?
Obstructive Sleep Apnea (OSA) — Applies to Medicaid plans. Initial approval: 2 months. Renewal: every 12 months.
What does Oklahoma Medicaid require to renew Zepbound?
Obstructive Sleep Apnea (OSA) — Applies to Medicaid plans. Member is tolerating maintenance dosing and adherent to therapy; clinical improvement of OSA (e.g., patient-reported improvement in daytime sleepiness, partner-reported reduction of snoring episodes or pauses in breathing, reduction of AHI events); member has not developed T1DM or T2DM; member is continuing a reduced calorie diet and increased physical activity in conjunction with Zepbound. Staying on a maintenance dose of at least 5 mg.
How current is this information?
The oldest review date among the policies on this page is June 4, 2026. Each policy's effective and verification dates appear with its requirements. Confirm current benefits with your plan.

Also under Oklahoma Medicaid: Mounjaro, Ozempic, Wegovy

Zepbound under other plans: HCSC, Alabama Medicaid, California Medicaid, Colorado Medicaid, Connecticut Medicaid, Delaware Medicaid, Illinois Medicaid, Indiana Medicaid

All insurance plans · All medications

Summary of Oklahoma Medicaid's written policy, not a guarantee of coverage. Plans vary by employer and benefit design.